EP 2424983 A1 20120307 - POLYPEPTIDES FOR THE IN VITRO ASSESSMENT OF THE SENSITISING POTENTIAL OF A TEST COMPOUND
Title (en)
POLYPEPTIDES FOR THE IN VITRO ASSESSMENT OF THE SENSITISING POTENTIAL OF A TEST COMPOUND
Title (de)
POLYPEPTIDE FÜR VERFAHREN ZUR BEWERTUNG DES SENSIBILITÄTSPOTENTIALS EINES TESTPRODUKTES
Title (fr)
POLYPEPTIDES POUR L'EVALUATION IN VITRO DU POTENTIEL SENSIBILISANT D ' UN COMPOSE TEST
Publication
Application
Priority
- EP 2010055895 W 20100430
- FR 0952929 A 20090430
Abstract (en)
[origin: WO2010125176A1] The invention relates to novel polypeptides and to the use thereof for the in vitro assessment of the sensitising potential of a test compound, to a method for the in vitro assessment of the sensitising potential of a test compound, to an in vitro method for selecting a compound suitable for reducing the sensitisation, as well as to kits for implementing such methods.
IPC 8 full level
C12N 9/64 (2006.01); C12N 9/90 (2006.01); G01N 33/50 (2006.01)
CPC (source: EP US)
C12N 9/6489 (2013.01 - EP US); C12N 9/90 (2013.01 - EP US); G01N 33/6881 (2013.01 - EP US); G01N 2500/02 (2013.01 - EP US); G01N 2500/04 (2013.01 - EP US); G01N 2500/20 (2013.01 - EP US)
Citation (search report)
See references of WO 2010125176A1
Citation (examination)
WO 2006078717 A2 20060727 - BETH ISRAEL HOSPITAL [US], et al
Designated contracting state (EPC)
AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO SE SI SK SM TR
DOCDB simple family (publication)
WO 2010125176 A1 20101104; BR PI1014622 A2 20150825; CA 2760685 A1 20101104; EP 2424983 A1 20120307; FR 2945042 A1 20101105; FR 2945042 B1 20160513; JP 2012525131 A 20121022; US 2012149130 A1 20120614; US 8703431 B2 20140422
DOCDB simple family (application)
EP 2010055895 W 20100430; BR PI1014622 A 20100430; CA 2760685 A 20100430; EP 10715868 A 20100430; FR 0952929 A 20090430; JP 2012507778 A 20100430; US 201013318064 A 20100430